Showing results (451-460 of 671) with videos related to

Sort By:
Pageof 68
Nature Cell Biology|December 1, 2025
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancerWarapen Treekitkarnmongkol, Hiroshi Katayama, Deivendran Sankaran, et al.
Cancer Research|December 2, 2010
Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signalingJames P Sullivan, Monica Spinola, Michael Dodge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid TumorsApostolia M Tsimberidou, Philip A Beer, Carrie A Cartwright, et al.
Nature Medicine|March 28, 2017
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancerJianjun Gao, John F Ward, Curtis A Pettaway, et al.
JAMA Oncology|March 10, 2017
A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung CancerDavid L Rimm, Gang Han, Janis M Taube, et al.
Nature Cell Biology|April 22, 2014
An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibitionLaetitia Seguin, Shumei Kato, Aleksandra Franovic, et al.
Cancer Research|January 8, 2014
A reevaluation of CD22 expression in human lung cancerLaurentiu M Pop, Stephen Barman, Chunli Shao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 16, 2018
De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancerAnju Singh, Christian Ruiz, Kavita Bhalla, et al.
Neoplasia (New York, N.Y.)|June 9, 2020
An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesisSuzie K Hight, Allison Mootz, Rahul K Kollipara, et al.
The Journal of Clinical Investigation|January 17, 2023
Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancerShidan Wang, Ruichen Rong, Donghan M Yang, et al.
Pageof 68